The Race for New Treatments for Graves Orbitopathy (Thyroid Eye Disease)
- PMID: 38451776
- DOI: 10.1210/clinem/dgad693
The Race for New Treatments for Graves Orbitopathy (Thyroid Eye Disease)
Keywords: FcRn; Graves disease; Graves orbitopathy; clinical trial; thyroid eye disease; thyroid stimulating immunoglobulins.
Comment on
-
Proof-of-concept and Randomized, Placebo-controlled Trials of an FcRn Inhibitor, Batoclimab, for Thyroid Eye Disease.J Clin Endocrinol Metab. 2023 Nov 17;108(12):3122-3134. doi: 10.1210/clinem/dgad381. J Clin Endocrinol Metab. 2023. PMID: 37390454 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
